Hospira Vinorelbine Tartrate 50 mg/5 mL Injection vial

Country: Ástralía

Tungumál: enska

Heimild: Department of Health (Therapeutic Goods Administration)

Virkt innihaldsefni:

vinorelbine tartrate, Quantity: 13.85 mg/mL

Fáanlegur frá:

Hospira Australia Pty Ltd

INN (Alþjóðlegt nafn):

Vinorelbine tartrate

Lyfjaform:

Injection

Samsetning:

Excipient Ingredients: water for injections

Stjórnsýsluleið:

Intravenous

Einingar í pakka:

1 X 5 mL

Tegund:

Medicine Listed (Export Only)

Gerð lyfseðils:

Not scheduled. Not considered by committee

Ábendingar:

Vinorelbine is indicated as a single agent or in combination with cisplatin for the first-line treatment of ambulatory patients with unresectable, advanced nonsmall cell lung cancer (NSCLC). In patients with Stage IV NSCLC, Vinorelbine is indicated as a single agent or in combination with cisplatin. In Stage III NSCLC, Vinorelbine is indicated in combination with cisplatin.

Vörulýsing:

Visual Identification: A clear, colourless to pale yellow solution & free from visible particulates; Container Type: Vial; Container Life Time: 2 Years; Container Temperature: Store at 2 to 8 degrees Celsius

Leyfisstaða:

Licence status A

Leyfisdagur:

2008-05-21